Skip to content

0.9% saline solution

DRUG16 trials

Sponsors

Bioaegis Therapeutics Inc., Sanofi Pasteur, a Sanofi Company, Medical University of Graz, Ever Neuro Pharma GmbH, Federal University of Uberlandia

Conditions

ARDSAcute Respiratory Distress Syndrome (ARDS) Due to Pneumonia or other InfectionsAscorbic AcidBreast CancerBronchiolitisChildrenEmergency LaparotomiesEndogenous Hyperinsulinism

Phase 1

Phase 2

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
CompletedNCT00442169
Sanofi Pasteur, a Sanofi CompanyWest Nile Fever
Start: 2005-12-31End: 2009-04-30Updated: 2016-04-14
Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.
TerminatedNCT02586961
Assistance Publique - Hôpitaux de ParisBronchiolitis, Children
Start: 2015-10-31End: 2017-10-31Updated: 2017-09-12
Evaluation of Skin Quality Improvement
CompletedNCT03097835
Steve Yoelin M.D. Medical Associates, Inc.Skin Quality
Start: 2018-02-12End: 2018-07-26Updated: 2019-02-22
Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS
CompletedNCT03567577
Apeptico Forschung und Entwicklung GmbHARDS
Start: 2018-05-23End: 2024-12-27Updated: 2025-05-14
Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation
NCT05754242
Hospital Universitario Ramon y CajalAscorbic Acid, Liver Transplantation, Postreperfusion Syndrome
Start: 2020-11-17End: 2023-07-30Target: 70Updated: 2023-03-03
Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies
RecruitingNCT05989386
Dow University of Health SciencesEmergency Laparotomies, Laparotomies, Post Operative Wound Infection +5
Start: 2023-04-29End: 2025-12-29Target: 200Updated: 2025-06-18
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard of Care for Moderate-to-Severe ARDS Due to Pneumonia or Other Infections
RecruitingCTIS2023-510109-16-00
Bioaegis Therapeutics Inc.Acute Respiratory Distress Syndrome (ARDS) Due to Pneumonia or other Infections
Start: 2025-01-06Target: 372Updated: 2026-01-19

Phase 3

Phase 4

Unknown Phase

Related Papers